YahooAugust 20, 2026 at 9:00 AM NY15 days ago

GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth

GSK PLC (LSE:GSK, NYSE:GSK) got a grudging nod from Citi on Thursday, as the investment bank lifted its earnings forecasts for the drugmaker but stopped well short of a buy call. The shares edged up 0.31% to 1,922p as Citi kept its 'neutral' rating, tweaking its model after GSK's...

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

CCitigroup Inc137.64− 0.37%

Companies in This Story

Related Stories